sleep disruption in chronic diseases
Conditions
Interventions
Group 1: Healthy subjects
Data on sleep, heart rate, oxygen saturation and activity are collected using a Fitbit tracker for a period of 24 weeks. After the data collection period has expired, the par
Sponsors
Medizinische Fakultät der Heinrich Heine Universität
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with chronic pain, patients with tumor diseases, patients with Parkinson's disease, healthy test subjects
Exclusion criteria
Exclusion criteria: Adults unable to consent and people who are in a dependent relationship with the study director. Patients who have increased sensitivity to light due to a previous illness or therapy or who suffer from serious muscoloskeletal impairments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sleep quality The objective sleep quality is recorded using a longitudinal Fitbit sleep analysis for 24 weeks. After the 24 weeks, subjective sleep quality (PSQI) is collected once using standardized questionnaires. | — |
Secondary
| Measure | Time frame |
|---|---|
| potential influencing factors on sleep quality The chronotype and chronotype-related parameters such as social jet lag and sleep loss are collected using longitudinal Fitbit sleep analysis for 24 weeks. After the 24 weeks, body measurements and general live living conditions, live style factors and depression/anxiety are evaluated once using questionnaire. The composition of the microbiome in the intestine and mucous membrane is checked using PCR. In addition, in patients, anamnesis, medical diagnosis and treatment procedures is collected from the patient's file and gene expression in the tumor and blood is examined using PCR. | — |
Countries
Germany
Contacts
Public ContactCharlotte von Gall
Medizinische Fakultät der Heinrich Heine Universität
Outcome results
None listed